DP
Congress trade
Sen. David Perdue (R-GA) sold $1K-$15K of Pfizer Inc. (PFE) stock
David Perdue, U.S. Senator (R-GA), disclosed a sale of Pfizer Inc. (PFE) stock worth $1K-$15K in a STOCK Act filing on Sep 4, 2018.
The trade happened on Aug 8, 2018, 27 days before it was made public.
PFE has moved -30.2% since the trade date, from $39.29 to $27.41 (Oct 5, 2026 close).
- Traded
- Aug 8, 2018
- Disclosed
- Sep 4, 2018
- Filing delay
- 27 days
- Price since
- -30.2%
- Source
- STOCK Act disclosure
Other trades in this disclosure (31)
- BuyAXTA$1K-$15KSep 4, 2018
- SellBAC$1K-$15KSep 4, 2018
- BuyCZR$1K-$15KSep 4, 2018
- BuyCZR$1K-$15KSep 4, 2018
- BuyCZR$1K-$15KSep 4, 2018
- SellDISCA$1K-$15KSep 4, 2018
- SellDISCA$1K-$15KSep 4, 2018
- SellDISCA$1K-$15KSep 4, 2018
- SellFDC$1K-$15KSep 4, 2018
- SellFDC$1K-$15KSep 4, 2018
- SellFDC$1K-$15KSep 4, 2018
- BuyFEYE$1K-$15KSep 4, 2018
- BuyFEYE$1K-$15KSep 4, 2018
- SellGLW$1K-$15KSep 4, 2018
- SellGLW$1K-$15KSep 4, 2018
- BuyGM$1K-$15KSep 4, 2018
- BuyHBI$1K-$15KSep 4, 2018
- SellMOS$1K-$15KSep 4, 2018
- SellMOS$1K-$15KSep 4, 2018
- SellMOS$1K-$15KSep 4, 2018
More PFE insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.